Literature DB >> 33375435

Posttranslational Modifications Pattern in Clear Cell Renal Cell Carcinoma.

Corina Daniela Ene1,2, Mircea Nicolae Penescu1,2, Simona Roxana Georgescu1,3, Mircea Tampa1,3, Ilinca Nicolae3.   

Abstract

Posttranslational modifications are dynamic enzymatic-mediated processes, regulated in time and space, associated with cancer development. We aimed to evaluate the significance of posttranslational modifications in the pathogenesis of clear cell renal cell carcinoma. The authors developed a prospective, observational study during a period of three years and included 55 patients with localized renal cell carcinoma and 30 heathy subjects. Glycosylation, nitration and carbonylation, thiol-disulfide homeostasis, methylation, phosphorylation and proteolytic cleavage were evaluated in the serum of the evaluated subjects in the present study. Our results showed some characteristics for early ccRCC: high production of cytokines, substrate hypersialylation, induced nitrosative and carbonylic stress, arginine hypermethylation, thiol/disulfide homeostasis (TDH) alteration, the regulatory role of soluble receptors (sRAGE, sIL-6R) in RAGE and IL-6 signaling, the modulatory effect of TK-1and TuM2-PK in controlling the level of phosphometabolites in neoplastic cells. These data could be the initial point for development of a panel of biomarkers such as total sialic acid, orosomucoids, nitrotyrosine, carbonylic metabolites, ADMA, SDMA, and thiol-disulfide equilibrium for early diagnosis of ccRCC. Moreover, they could be considered a specific disease PTM signature which underlines the transition from early to advanced stages in this neoplasia, and of a therapeutic target in kidney oncogenesis.

Entities:  

Keywords:  carbonylation; cytokines; glycosylation; methylation; nitrosative stress; phosphorylation; posttranslational modification; protein cleavage; renal cell carcinoma; thiol/disulfide equilibrium

Year:  2020        PMID: 33375435      PMCID: PMC7824589          DOI: 10.3390/metabo11010010

Source DB:  PubMed          Journal:  Metabolites        ISSN: 2218-1989


  101 in total

1.  Circulating tumor M2 pyruvate kinase and thymidine kinase 1 are potential predictors for disease recurrence in renal cell carcinoma after nephrectomy.

Authors:  Benjamin Nisman; Vladimir Yutkin; Hovav Nechushtan; Ofer N Gofrit; Tamar Peretz; Simon Gronowitz; Dov Pode
Journal:  Urology       Date:  2010-06-22       Impact factor: 2.649

2.  Marker for renal cell carcinoma (RCC): the dimeric form of pyruvate kinase type M2 (Tu M2-PK).

Authors:  H W Wechsel; E Petri; K H Bichler; G Feil
Journal:  Anticancer Res       Date:  1999 Jul-Aug       Impact factor: 2.480

3.  Abnormal high-density lipoprotein induces endothelial dysfunction via activation of Toll-like receptor-2.

Authors:  Thimoteus Speer; Lucia Rohrer; Przemyslaw Blyszczuk; Rukshana Shroff; Kira Kuschnerus; Nicolle Kränkel; Gabriela Kania; Stephen Zewinger; Alexander Akhmedov; Yi Shi; Tina Martin; Damir Perisa; Stephan Winnik; Maja F Müller; Urban Sester; Gabriel Wernicke; Andreas Jung; Ursula Gutteck; Urs Eriksson; Jürgen Geisel; John Deanfield; Arnold von Eckardstein; Thomas F Lüscher; Danilo Fliser; Ferdinand H Bahlmann; Ulf Landmesser
Journal:  Immunity       Date:  2013-03-07       Impact factor: 31.745

4.  IL-6/IL-6R axis plays a critical role in acute kidney injury.

Authors:  Yael Nechemia-Arbely; Daniel Barkan; Galina Pizov; Anat Shriki; Stefan Rose-John; Eithan Galun; Jonathan H Axelrod
Journal:  J Am Soc Nephrol       Date:  2008-03-12       Impact factor: 10.121

5.  High glucose-mediated imbalance of nitric oxide synthase and dimethylarginine dimethylaminohydrolase expression in endothelial cells.

Authors:  Valeria Sorrenti; Francesco Mazza; Agata Campisi; Luca Vanella; Giovanni Li Volti; Claudia Di Giacomo
Journal:  Curr Neurovasc Res       Date:  2006-02       Impact factor: 1.990

6.  3-Nitrotyrosine as a biomarker for vascular involvement in Fabry disease.

Authors:  Dominique A Joly; Jean-Pierre Grünfeld
Journal:  Kidney Int       Date:  2014-07       Impact factor: 10.612

Review 7.  Is there any evidence that AGE/sRAGE is a universal biomarker/risk marker for diseases?

Authors:  Kailash Prasad
Journal:  Mol Cell Biochem       Date:  2018-06-30       Impact factor: 3.396

8.  Decreased nephrin and GLEPP-1, but increased VEGF, Flt-1, and nitrotyrosine, expressions in kidney tissue sections from women with preeclampsia.

Authors:  Shuang Zhao; Xin Gu; Lynn J Groome; Yuping Wang
Journal:  Reprod Sci       Date:  2009-06-15       Impact factor: 3.060

Review 9.  Toxic Dimethylarginines: Asymmetric  Dimethylarginine (ADMA) and Symmetric  Dimethylarginine (SDMA).

Authors:  You-Lin Tain; Chien-Ning Hsu
Journal:  Toxins (Basel)       Date:  2017-03-06       Impact factor: 4.546

10.  Asymmetric and symmetric dimethylarginines and mortality in patients with hematological malignancies-A prospective study.

Authors:  Angelika Chachaj; Jerzy Wiśniewski; Justyna Rybka; Aleksandra Butrym; Monika Biedroń; Małgorzata Krzystek-Korpacka; Mariusz Grzegorz Fleszar; Maciej Karczewski; Tomasz Wróbel; Grzegorz Mazur; Andrzej Gamian; Andrzej Szuba
Journal:  PLoS One       Date:  2018-05-22       Impact factor: 3.240

View more
  4 in total

1.  COLGALT1 is a potential biomarker for predicting prognosis and immune responses for kidney renal clear cell carcinoma and its mechanisms of ceRNA networks.

Authors:  Shiwei Liu; Yang Yu; Yi Wang; Bingye Zhu; Bangmin Han
Journal:  Eur J Med Res       Date:  2022-07-16       Impact factor: 4.981

Review 2.  IL-6 Signaling Link between Inflammatory Tumor Microenvironment and Prostatic Tumorigenesis.

Authors:  Cosmin-Victor Ene; Ilinca Nicolae; Bogdan Geavlete; Petrisor Geavlete; Corina Daniela Ene
Journal:  Anal Cell Pathol (Amst)       Date:  2022-04-12       Impact factor: 4.133

Review 3.  Structural aspects of chemical modifications in the MHC-restricted immunopeptidome; Implications for immune recognition.

Authors:  Tatyana Sandalova; Benedetta Maria Sala; Adnane Achour
Journal:  Front Chem       Date:  2022-08-09       Impact factor: 5.545

Review 4.  Mass spectrometry-based N-glycosylation analysis in kidney disease.

Authors:  Weifu Ren; Qi Bian; Yan Cai
Journal:  Front Mol Biosci       Date:  2022-08-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.